New Webinar: Optimizing Analytics for Biosimilars

How Providing Comprehensive Data Can Accelerate Drug Development[more]

Date 21.04.2016     Category Products, Sartorius Stedim Biotech

Q1 Results: Sartorius Off to a Dynamic Start in 2016

Double-digit gains in the Bioprocess Solutions Division; positive development of the Lab Products & Services Division | Overproportionate increase in earnings | Positive outlook for the full year...[more]

Date 20.04.2016     Category Corporate, Sartorius

First-quarter Figures: Sartorius Stedim Biotech off to a dynamic start into 2016

€ in millions unless otherwise specified Unaudited figures 3 months 2016 3 months 2015 Growth in % Growth in % const. fx Order intake 274.1 224.1 22.3 23.0 Sales revenue 245.8 204.4 20.2...[more]

Date 20.04.2016     Category Corporate, Sartorius Stedim Biotech

Resolutions of the Annual Shareholders' Meeting of Sartorius AG

Annual Shareholders' Meeting passes resolution to pay dividends of 1.52 euros per preference share and 1.50 euros per ordinary share | Approval of share capital increase by use of retained earnings...[more]

Date 07.04.2016     Category Corporate, Sartorius

Sartorius Stedim Biotech to present and exhibit at the BioProcess International European Summit in Vienna

Goettingen, April 6, 2016 – Sartorius Stedim Biotech, an international leading supplier for the biopharmaceutical industry, will be presenting and exhibiting at the BioProcess International European...[more]

Date 06.04.2016     Category Products, Sartorius Stedim Biotech